Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Patients who added Cabometyx to Opdivo and Yervoy had a 27% lower risk of disease progression or death.
Starting Keytruda before surgery improves the outlook for patients with Stage III-IV melanoma.
Researchers found that shutting down the effects of the abnormal collagen made treatments for pancreatic cancer more effective.
Cancer drugs called immune checkpoint inhibitors can cause itching and painful skin rashes. But what triggers these side effects?
People with a prior history of heart disease were at greater risk when treated with immune checkpoint inhibitors.
Allergy meds were linked to longer survival among cancer patients treated with immune checkpoint inhibitors.
In a small trial, Jemperli led to complete remission in people with a biomarker for deficient DNA repair.
Researchers hope to easily identify which colon cancer patients are unlikely to benefit from immune checkpoint inhibitors (ICIs).
People with a specific variant of the CTLA-4 gene had exceptionally good responses to PD-1 checkpoint inhibitors.
An intravenous infusion of two immunotherapy drugs, Opdualag blocks activity of the proteins LAG-3 and PD-1.
The institute aims to develop new cancer treatments and bring the benefits of immunotherapy to all patients.
Neoadjuvant Opdivo plus chemotherapy improved outcomes for people with operable non-small-cell lung cancer.
New clues help explain why only 10-15% of ovarian cancer patients respond favorably to immune checkpoint inhibitor therapy.
Adding radiation therapy to Imfinzi and tremelimumab didn’t help those with non-small cell lung cancer, according to a new study.
Medications that block the PSGL-1 protein promote an anti-tumor immune response in people with melanoma.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.